record #496398079220999 | shh | 92547244 | | 5799826 | 5/29/2004 12:00:00 am | dizziness | | dis | admission date: 5/29/2004 report status:discharge date: 7/17/2004 discharge orders corkill , mickey 625-13-08-7rhamcastaleah nonoservice: meddischarge patient on: 9/0/04 at 06:00 pmcontingent upon ho evaluationwill d/c order be used as the d/c summary: yesattending: dewyse , kendall j. , m.d.code status:full codedisposition: homedischarge medications:acetylsalicylic acid 81 mg po qd starting stat ( 0/17 )alert overridden: override added on 8/6/04 bylahue , henry , m.d.potentially serious interaction: warfarin &amp; aspirinreason for override: md aware , pt on this regimen at homeamiodarone 200 mg po qdalert overridden: override added on 8/6/04 bydyment , isaac , m.d.potentially serious interaction: warfarin &amp; amiodarone hclserious interaction: digoxin &amp; amiodarone hclreason for override: md aware pt on this regimen at homedigoxin 0.125 mg po qdoverride notice: override added on 8/6/04 bymurie , elliott , m.d.on order for amiodarone po ( ref # 75986840 )serious interaction: digoxin &amp; amiodarone hclreason for override: md aware pt on this regimen at homecolace ( docusate sodium ) 100 mg po bidlasix ( furosemide ) 120 mg po bidnph humulin insulin ( insulin nph human ) 47 units sc qaminsulin regular humansliding scale ( subcutaneously ) sc ac+hsif bs is less than 125 , then give 0 units subcutaneouslyif bs is 125-150 , then give 2 units subcutaneouslyif bs is 151-200 , then give 3 units subcutaneouslyif bs is 201-250 , then give 4 units subcutaneouslyif bs is 251-300 , then give 6 units subcutaneouslyif bs is 301-350 , then give 8 units subcutaneouslyif bs is 351-400 , then give 10 units subcutaneously andcall ho call ho if bs is greater than 400milk of magnesia ( magnesium hydroxide )30 milliliters po qd prn constipationcoumadin ( warfarin sodium ) 2 mg po qpmstarting now , within hour of pharmacy approval ( 0/17 )food/drug interaction instructionno high vitamin-k containing foodsoverride notice: override added on 8/6/04 bypalen , everette , m.d.on order for acetylsalicylic acid po ( ref # 44957141 )potentially serious interaction: warfarin &amp; aspirinreason for override: md aware , pt on this regimen at homeprevious override information:override added on 8/6/04 by loterbauer , porter , m.d.on order for amiodarone po ( ref # 75986840 )potentially serious interaction: warfarin &amp; amiodarone hclreason for override: md aware pt on this regimen at homeprevious override information:override added on 9/23/04 by odonald , emanuel , m.d.potentially serious interaction: simvastatin &amp; warfarinreason for override: md awaresimvastatin 80 mg po qhs starting stat ( 4/13 )food/drug interaction instructionavoid grapefruit unless md instructs otherwise.override notice: override added on 9/23/04 bykidwell , richie , m.d.on order for coumadin po ( ref # 55008411 )potentially serious interaction: simvastatin &amp; warfarinreason for override: md awarenorvasc ( amlodipine ) 10 mg po qd hold if: sbp &lt; 95food/drug interaction instructionavoid grapefruit unless md instructs otherwise.imdur ( isosorbide mononit.( sr ) ) 60 mg po qdfood/drug interaction instructiongive on an empty stomach ( give 1hr before or 2hr afterfood )kcl immediate release 40 meq po bidhold if: potassium &gt; 4.5as per ich potassium chloride policy:each 20 meq dose to be given with 4 oz of fluidcozaar ( losartan ) 100 mg po qhs starting stat ( 4/13 )hold if: sbp &lt; 95 number of doses required ( approximate ): 3plavix ( clopidogrel ) 75 mg po qd starting stat ( 0/17 )nexium ( esomeprazole ) 20 mg po qdlevothyroxine sodium 50 mcg po qdalert overridden: override added on 9/0/04 by :potentially serious interaction: digoxin &amp; levothyroxinesodium reason for override: awarediet: house / 2 gm na / ada 2100 cals/day / low saturated fatlow cholesterolactivity: resume regular exercisefollow up appointment( s ):dr. kirkconnell ( cardiology 521-540-0293 ) at 11:00am 9/22/04 ,dr. mccaffrey ( pcp 221-764-2384 ) at 10:45am 5/8/04 ,dr. ziebol ( endocrinology 091-018-1923 ) at 3:00pm 10/11/04 ,arrange inr to be drawn on 9/22/04 with f/u inr's to be drawn every7 days. inr's will be followed by dr. mac strogenallergy: cephalosporins , erythromycin , penicillinsadmit diagnosis:dizziness , ataxiaprincipal discharge diagnosis ;responsible after study for causing admission )dizzinessother diagnosis;conditions , infections , complications , affecting treatment/stays/p right cea lbbb on ekg hypertensiondiabetes ef 25-30% chf ( congestive heartfailure ) ischemic cardiomyopathy ( cardiomyopathy ) atrial fibrillation( atrial fibrillation ) , symptomatic bradycardia s/p aicd/pacerplacement , ?tiaoperations and procedures:noneother treatments/procedures ( not in o.r. )chest pa and lateral.aicd interrogation ( dr. kurt morring )brief resume of hospital course:ms galabeas is a 71f with dm , cad , s/p 3vcabg , s/p rca stent in 1/2 ,chf( ef=45% in 1/2 ) , h/o bradycardia now with aicd/pacer , s/p r-cea ,s/p ? tia , who presents with dizziness , ataxia x 24h.pt denies cp , sob , palpitations. pt denies melana; brbpr. no new meds ,no n/v/f/c. this is unlike anything she has had in the past.in the ed , labs were all within normal limits. while on a monitor shehad an episode of bradycardia to the 40s. dr. hilmer ofthe ep service interogated the device and indicated that it wasworking properly with no arrhythmias. telemetry in the ed also didnot record the bradycardic episode , suggesting that perhaps it was anartifact. pt's toxicology screen was negative. her vitals in the ed were 98.0 , 55 , 176/60 , 18 , 98%ra. no dysmetria; no dysdiadocokinesia;negativ e romberg's sign.hospital course:1. cv: pt ruled out for mi; 24h telemetry showed no arrhythmias.pt's bb was held while in house because of worry aboutbradyarrhythmia , hypotension. continued antihypertensive and cadtreatment with with cozaar , lasix , norvasc , isosorbide , digoxin ,amiodarone. pt is also on coumadin , plavix , and asa , which wascontinued in house. pt was discussed w/ pt's cardiologist , dr.kallio who indicated this was not a new complaint in the patient andalso that she has been non-compliant in the past. pt was on coreg butthis was held prior to admit for low bp's. pt was hypertensive w/ sbp 150's while inpt but we will d/c pt off coreg and defer to dr.doniel for reinstitution of beta blockade2. neuro: pt's neuro exam was normal with no focal signs , and no signsof cerebellar dysfunction. nevertheless given her significant vascularrisk factors there was concern for vertebral-basilar insufficiency.mri/mra was not possible given pt's aicd/pacer. upon discussion w/team ct/cta were deferred given pt's renal insufficiency and risk ofcontrast nephropathy coupled with our feeling that any findings wouldnot change pt management. this will be discussed with pt's pcp , dr.benedict wichern .3. endo: pt was continued on home insulin regimen with coverage withinsulin sliding scale. pt was found have a tsh of 158 ft4 1.8 , ft3 56.upon discussion w/ pt , she revealed that she had previously beendiagnosed and begun on replacement but did not know what it was for andsubsequently stopped it on her own. pt started on synthroid to be f/uw/endocrine. this may be the etiology of her symptoms.4. prophylaxis: nexium; pt was already anticoagulated with asa , plavixand coumadin.5. disp: pt to follow-up w/ dr. kishaba for managment of chf/bp , andwith dr. blagg for f/u of potential neurovascular etiology of symptoms.pt to f/u with endocrinology for managment of hypothyroidism.additional comments:discharge condition: stableto do/plan:1. continue levothyroxine for hypothyroidism. f/u endo for management2. f/u w/ dr. schryer for possible reinstitution of beta blockade andchf/bp management3. f/u dr. hackborn for w/u potential vertebral-basilar insufficieny withrecognition of risk of iv contrast nephropathy vs utility ofinformationno dictated summaryentered by: cramm , alan , m.d. ( jx65 ) 9/0/04 @ 06:12 pm end of discharge orders [report_end]